Anteris Technologies is known for its biomimetic transcatheter heart valve, the DurAVR THV System. The device is the first of its kind and has gained considerable attention as the TAVR market continues to grow.

Abbott pointed to double-digit growth for its Navitor TAVR valve as well as big gains for the TriClip and MitraClip devices. The company also shared positive sales figures for its EP, heart failure and rhythm management portfolios. 

Last month, the Republican and Democratic Doctors Caucuses sent an informal request to medical societies, seeking ways to reform Medicare’s push toward value-based care. 

UnitedHealth Group CEO Stephen Hemsley is expected to make the announcement in front of Congress, where he will also offer other policy solutions. The company said it’s still working out details on how to best distribute its profits to customers. 

Johnson & Johnson reported $24.6 billion in sales for the fourth quarter of 2025, up 9.1% from the previous year. On an earnings call with investors, the company's CEO sang the praises of the company's cardiovascular health division.

2026 may be the year that many if not most healthcare leaders arrive at a fork in the road to mature AI implementation. 

The bill announced by two Democratic members of the state House of Representatives would guarantee coverage to everyone in the commonwealth—but many of the details have yet to be revealed. 

Where have the missing rural American hospitals gone? And where is rural healthcare headed? The discussion is on in Washington and elsewhere.